Photo of Bexis

When we’re blogging, sometimes we feel like we’re doing legal research or trying to advance the law.

Other times, we feel like we’re just nudging our friends, so they don’t overlook something that might interest them.

This post is of the friendly sort:

Don’t overlook this article in this morning’s Wall Street Journal about the intense lobbying behind the scenes in Wyeth v. Levine. (The reference, near the bottom, to the “Drug and Device Makers Preemption Conference” is seemingly about the ACI conference that the two of us co-chaired in Philadelphia last month. We’re always glad to be involved in this particular debate.)

Drug & Device Resources

Bexis’ Book

FDA-regulated products now account for an estimated one-fifth of overall economic activity in the U.S. They have also been the focus of a litigation explosion. This timely guide covers all aspects of litigation involving drugs, medical devices, vaccines and other FDA-regulated prescription products.
Learn More About This Book